Comparison of Inflammatory Markers and Lipid Profile Between High-dose Rosuvastatin Monotherapy and Ezetimibe/Rosuvastatin Combination Therapy

被引：0
|
作者：
Yamazaki, Daisuke [1 ]
Ishida, Masaru [1 ]
Nobori, Kiyoshi [1 ]
Oguma, Yasunori [1 ]
Terata, Yutaka [1 ]
Koyama, Takashi [1 ]
Iino, Kenji [1 ]
Kosaka, Toshimitsu [1 ]
Watanabe, Hiroyuki [1 ]
Ito, Hiroshi [1 ]
机构：
[1] Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita 010, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2012年 / 18卷 / 10期
关键词：
D O I：
10.1016/j.cardfail.2012.08.202
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [31] Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers
    van Himbergen, Thomas M.
    Matthan, Nirupa R.
    Resteghini, Nancy A.
    Otokozawa, Seiko
    Ai, Masumi
    Stein, Evan A.
    Jones, Peter H.
    Schaefer, Ernst J.
    JOURNAL OF LIPID RESEARCH, 2009, 50 (04) : 730 - 739
  • [32] Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate- intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III Study
    Lee, Seung-Ah
    Kim, Weon
    Hong, Taek Jong
    Ahn, Youngkeun
    Kim, Moo Hyun
    Hong, Soon Jun
    Kim, Bong Sik
    Kim, Seok Yeon
    Chae, In-Ho
    Kim, Byung Jin
    Rhee, Moo-Yong
    Shin, Joon Han
    Kang, Tae Soo
    Cho, Jin Man
    Kim, Jung-Sun
    Lee, Cheol Whan
    CLINICAL THERAPEUTICS, 2021, 43 (09) : 1573 - +
  • [33] A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial
    Hong, Soon Jun
    Jeong, Han Saem
    Ahn, Jeong Cheon
    Cha, Dong-Hun
    Won, Kyung Heon
    Kim, Weon
    Cho, Sang Kyoon
    Kim, Seok-Yeon
    Yoo, Byung-Su
    Sung, Ki Chul
    Rha, Seung-Woon
    Shin, Joon-Han
    Han, Kyoo Rok
    Chung, Wook Sung
    Hyon, Min Su
    Lee, Han Cheol
    Bae, Jang-Ho
    Rhee, Moo-Yong
    Kwan, Jun
    Jeon, Dong Woon
    Yoo, Ki Dong
    Kim, Hyo-Soo
    CLINICAL THERAPEUTICS, 2018, 40 (02) : 226 - 241
  • [34] COMPARISON OF ROSUVASTATIN PLUS OMEGA-3 FATTY ACIDS COMBINATION THERAPY AND ROSUVASTATIN MONOTHERAPY IN THE TREATMENT OF MIXED HYPERLIPIDEMIA: A 8 WEEKS RANDOMIZED TRIAL
    Lee, S. U.
    Kang, D. G.
    Cho, S. K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [35] EFFECT OF PRE LOADING WITH HIGH-DOSE OF ROSUVASTATIN IN GENE EXPRESSION AND SERUM LEVELS OF INFLAMMATORY MARKERS AFTER PCI WITH METALLIC STENTS
    Slhessarenko, Juliano R.
    Costa, Jose de Ribamar
    Abizaid, Alexandre
    Hirata, Mario
    Bastos, Gisele Medeiros
    Carvalho, Guilherme Sobreira
    Slhessareko, Renata Dezengrini
    Sousa, Amanda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 167 - 167
  • [36] Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis
    Yang, Han
    Li, Nan
    Zhou, Youlian
    Xiao, Zhilan
    Tian, Haoming
    Hu, Ming
    Li, Sheyu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 157 - 165
  • [37] Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
    Olszewska-Banaszczyk, Malgorzata
    Jackowska, Paulina
    Gorzelak-Pabis, Paulina
    Pytel, Edyta
    Koter-Michalak, Maria
    Broncel, Marlena
    PHARMACOLOGICAL REPORTS, 2018, 70 (02) : 258 - 262
  • [38] The effects and safety between high-dose Atorvastatin and Rosuvastatin in Acute myocardial infarction patients
    Zhang Wenduo
    Wang Fang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C206 - C206
  • [39] Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
    Małgorzata Olszewska-Banaszczyk
    Paulina Jackowska
    Paulina Gorzelak-Pabiś
    Edyta Pytel
    Maria Koter-Michalak
    Marlena Broncel
    Pharmacological Reports, 2018, 70 : 258 - 262
  • [40] Pharmacokinetic comparison of a fixed-dose combination of telmisartan/rosuvastatin/ezetimibe/amlodipine 80/20/10/5 mg and a loose-dose combination of ezetimibe/rosuvastatin 10/20 mg and telmisartan/amlodipine 80/5 mg in healthy male subjects
    Lee, Sooyoun
    Kim, Hyun Chul
    Kim, Kyung Tae
    Kang, Seung-Hyun
    Lee, Seunghwan
    Yu, Kyung-Sang
    Lee, Soyoung
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
12345